1. For patients with severe ischemic left ventricular systolic dysfunction on optimal medical therapy, percutaneous coronary intervention (PCI) did not ...
1. In high-risk patients who had undergone percutaneous coronary intervention (PCI), routine functional testing did not improve clinical outcomes compared ...
1. Fractional flow reserve (FFR) guidance for percutaneous coronary intervention (PCI) was non-inferior to intravascular ultrasonography (IVUS) guidance. 2. Patient-reported ...
![Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Taxus_stent_FDA-e1607803635904-350x250.jpg)
1. Guided selection of antiplatelet therapy reduced rates of major adverse cardiovascular event rates compared to standard therapy. 2. Guided ...
1. Patients without standard modifiable cardiovascular risk factors (SMuRFs) had a significantly higher all-cause mortality at 30 days after first ...
1. There was no significant difference in periprocedural myonecrosis between ticagrelor and clopidogrel among patients undergoing high-risk elective PCI. 2. ...
1. In a modern cohort of patients with readily available primary percutaneous coronary intervention, woman experienced greater mortality rates then ...
1. Amongst patients undergoing angiography, neither sodium bicarbonate nor acetylcysteine were effective in preventing a composite outcome of death, need ...
1. On average, in this cross-sectional study, physician visual assessment overestimated coronary stenosis severity as compared to quantitative coronary angiography. ...
1. In patients with acute myocardial infarction (MI) with cardiogenic shock and multivessel coronary disease, culprit-lesion-only percutaneous coronary intervention (PCI) ...
